341 related articles for article (PubMed ID: 18391135)
1. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people.
Myrick H; Anton RF; Li X; Henderson S; Randall PK; Voronin K
Arch Gen Psychiatry; 2008 Apr; 65(4):466-75. PubMed ID: 18391135
[TBL] [Abstract][Full Text] [Related]
2. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence.
Ait-Daoud N; Johnson BA; Prihoda TJ; Hargita ID
Psychopharmacology (Berl); 2001 Feb; 154(1):23-7. PubMed ID: 11292002
[TBL] [Abstract][Full Text] [Related]
3. Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder.
Karl D; Bumb JM; Bach P; Dinter C; Koopmann A; Hermann D; Mann K; Kiefer F; Vollstädt-Klein S
Psychopharmacology (Berl); 2021 Aug; 238(8):2179-2189. PubMed ID: 33846866
[TBL] [Abstract][Full Text] [Related]
4. Alcohol Cue-Induced Ventral Striatum Activity Predicts Subsequent Alcohol Self-Administration.
Lim AC; Green R; Grodin EN; Venegas A; Meredith LR; Donato S; Burnette E; Ray LA
Alcohol Clin Exp Res; 2020 Jun; 44(6):1224-1233. PubMed ID: 32406553
[TBL] [Abstract][Full Text] [Related]
5. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence.
Johnson BA; Ait-Daoud N; Prihoda TJ
Alcohol Clin Exp Res; 2000 May; 24(5):737-42. PubMed ID: 10832917
[TBL] [Abstract][Full Text] [Related]
6. Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging.
Mann K; Vollstädt-Klein S; Reinhard I; Leménager T; Fauth-Bühler M; Hermann D; Hoffmann S; Zimmermann US; Kiefer F; Heinz A; Smolka MN
Alcohol Clin Exp Res; 2014 Nov; 38(11):2754-62. PubMed ID: 25421512
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.
Schacht JP; Randall PK; Latham PK; Voronin KE; Book SW; Myrick H; Anton RF
Neuropsychopharmacology; 2017 Dec; 42(13):2640-2653. PubMed ID: 28409564
[TBL] [Abstract][Full Text] [Related]
8. Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients.
Spagnolo PA; Ramchandani VA; Schwandt ML; Zhang L; Blaine SK; Usala JM; Diamond KA; Phillips MJ; George DT; Momenan R; Heilig M
Alcohol Clin Exp Res; 2014 Dec; 38(12):3024-32. PubMed ID: 25581657
[TBL] [Abstract][Full Text] [Related]
9. Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial.
Garbutt JC; Kampov-Polevoy AB; Kalka-Juhl LS; Gallop RJ
JAMA Psychiatry; 2016 Oct; 73(10):1056-1063. PubMed ID: 27627782
[TBL] [Abstract][Full Text] [Related]
10. Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker.
Ait-Daoud N; Johnson BA; Javors M; Roache JD; Zanca NA
Alcohol Clin Exp Res; 2001 Jun; 25(6):847-9. PubMed ID: 11410720
[TBL] [Abstract][Full Text] [Related]
11. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving.
Heinz A; Siessmeier T; Wrase J; Hermann D; Klein S; Grüsser SM; Flor H; Braus DF; Buchholz HG; Gründer G; Schreckenberger M; Smolka MN; Rösch F; Mann K; Bartenstein P
Am J Psychiatry; 2004 Oct; 161(10):1783-9. PubMed ID: 15465974
[TBL] [Abstract][Full Text] [Related]
12. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial.
Johnson BA; Roache JD; Javors MA; DiClemente CC; Cloninger CR; Prihoda TJ; Bordnick PS; Ait-Daoud N; Hensler J
JAMA; 2000 Aug 23-30; 284(8):963-71. PubMed ID: 10944641
[TBL] [Abstract][Full Text] [Related]
13. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil.
Heinz A; Reimold M; Wrase J; Hermann D; Croissant B; Mundle G; Dohmen BM; Braus DF; Schumann G; Machulla HJ; Bares R; Mann K
Arch Gen Psychiatry; 2005 Jan; 62(1):57-64. PubMed ID: 15630073
[TBL] [Abstract][Full Text] [Related]
14. Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues.
Ray LA; Courtney KE; Hutchison KE; Mackillop J; Galvan A; Ghahremani DG
Alcohol Clin Exp Res; 2014 Jan; 38(1):78-89. PubMed ID: 23876228
[TBL] [Abstract][Full Text] [Related]
15. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
[TBL] [Abstract][Full Text] [Related]
16. Investigation of brain functional connectivity to assess cognitive control over cue-processing in Alcohol Use Disorder.
Strosche A; Zhang X; Kirsch M; Hermann D; Ende G; Kiefer F; Vollstädt-Klein S
Addict Biol; 2021 Jan; 26(1):e12863. PubMed ID: 31908107
[TBL] [Abstract][Full Text] [Related]
17. The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics.
Myrick H; Li X; Randall PK; Henderson S; Voronin K; Anton RF
J Clin Psychopharmacol; 2010 Aug; 30(4):365-72. PubMed ID: 20571434
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin modulates mesolimbic reactivity to alcohol cues in alcohol-addicted subjects: a functional imaging study.
Koopmann A; Bach P; Schuster R; Bumb JM; Vollstädt-Klein S; Reinhard I; Rietschel M; Witt SH; Wiedemann K; Kiefer F
Addict Biol; 2019 Sep; 24(5):1066-1076. PubMed ID: 29984874
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent.
Lim AC; Ghahremani DG; Grodin EN; Green R; Bujarski S; Hartwell EE; Courtney KE; Hutchison K; Miotto K; Ray LA
Drug Alcohol Depend; 2019 Jul; 200():181-190. PubMed ID: 31160146
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.
Anton RF; Oroszi G; O'Malley S; Couper D; Swift R; Pettinati H; Goldman D
Arch Gen Psychiatry; 2008 Feb; 65(2):135-44. PubMed ID: 18250251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
